About NxThera
NxThera is a company based in Maple Grove (United States) founded in 2008 was acquired by Boston Scientific in March 2018. NxThera has raised $148.28 million across 12 funding rounds from investors including Boston Scientific, American Medical Systems and Aberdare Ventures. The company has 77 employees as of December 31, 2017. NxThera operates in a competitive market with competitors including Francis Medical, Combat Medical, Kaio Therapy, MedWaves and Vither Hyperthermia, among others.
- Headquarter Maple Grove, United States
- Employees 77 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$148.28 M (USD)
in 12 rounds
-
Latest Funding Round
$20.61 M (USD), Series D
Jul 19, 2017
-
Investors
Boston Scientific
& 8 more
-
Employee Count
77
as on Dec 31, 2017
-
Acquired by
Boston Scientific
(Mar 21, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NxThera
NxThera has successfully raised a total of $148.28M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $20.61 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NxThera
NxThera has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, American Medical Systems and Aberdare Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US Life-Sciences sectors are targeted for investment by Aberdare Ventures.
|
Locked | Locked | Locked | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked |
Investor details for NxThera
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NxThera
Investment portfolio details for NxThera
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NxThera
Detailed financials for NxThera
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nxthera Comparisons
Peer comparison for NxThera
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NxThera
NxThera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Francis Medical, Combat Medical, Kaio Therapy, MedWaves and Vither Hyperthermia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer
|
|
| Locked | Locked | Locked |
Thermotherapy devices for bladder cancer treatment are manufactured.
|
|
| Locked | Locked | Locked |
Hyperthermia-based cancer therapeutic platform is developed using nanoparticles.
|
|
| Locked | Locked | Locked |
Soft tissue issues are addressed through thermal ablation systems.
|
|
| Locked | Locked | Locked |
A cancer therapy in which the body is heated to 42°C for 2 hours
|
Detailed competitors of NxThera
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nxthera
Complete news archive for NxThera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NxThera
NxThera was founded in 2008.
NxThera is headquartered in Maple Grove, United States. It is registered at Maple Grove, Minnesota, United States.
NxThera is a funded company, having raised a total of $148.28M across 12 funding rounds to date.
As of Dec 31, 2017, the latest employee count at NxThera is 77.
NxThera was founded in 2008 in Maple Grove, United States, within the medical device sector. Thermal therapy for treating benign prostatic hyperplasia (BPH) is developed by the company. The Rezum System is employed, utilizing radiofrequency energy to produce sterile water vapor. Controlled thermal energy is delivered via heat convection to obstructive prostate tissue. Outpatient procedures are supported for this minimally invasive approach.
NxThera's top competitors include Francis Medical, Combat Medical and Kaio Therapy.
NxThera has 9 investors. Key investors include Boston Scientific, American Medical Systems, Aberdare Ventures, Arboretum Ventures, and Ally Bridge Group.